Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA01 - Advanced Diagnostic Approaches for Intrathoracic Lymph Nodes and Peripheral Lung Tumors
- 10:30 - 12:00
- 9/08/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Oral Session
- Track: Interventional Diagnostics/Pulmonology
- Moderators:Marioara Simon, Tim Murgu
-
+
OA01.01 - Predictive Value of EBUS Strain Elastography in Mediastinal Lymph Node Staging; The E-Predict Multicenter Study Results
10:30 - 10:40 | Presenter: Roel L.J. Verhoeven | Author(s): Rocco Trisolini, Fausto Leoncini, Michela Bezzi, Piero Candoli, Alessandro Messi, Mark Krasnik, Jouke Annema, Chris de Korte, Erik H.F.M. Van Der Heijden
- Abstract
Loading... -
+
OA01.02 - Endobronchial Ultrasound Staging of Operable NSCLC: Triple Negative Lymph Nodes May Not Require Routine Biopsy
10:40 - 10:50 | Presenter: Danielle Hylton | Author(s): Kaesavan Selvakumaran, Biniam Kidane, Jonathan D. Spicer, Simon R Turner, Daniel French, Chuck Wen, James Masters, Yogita S. Patel, Jenelle Taylor, Christian Finley, Yaron Shargall, Forough Farrokhyar, John Agzarian, Andrew Seely, Kazuhiro Yasufuku, Wael C. Hanna
- Abstract
Loading... -
+
OA01.03 - Probability Model for Malignancy in Hilar and Mediastinal Lymph Nodes in Lung Cancer Based on PET-CT and EBUS
10:50 - 11:00 | Presenter: Jaume Bordas-Martinez | Author(s): Jose Luis Vercher Conejero, Guillermo Rodríguez Gonzalez, Paula Notta, Cristian Tebé Cordomi, Cristina Martín Cabeza, Noelia Cubero De Frutos, María Rosa López-Lisbona, Marta Díez-Ferrer, Nuria Baixeras Gonzalez, Cristina Gamez Cenzano, Jordi Dorca Sargatal, Antoni Rosell
- Abstract
Loading... -
+
OA01.04 - Discussant - OA01.01, OA01.02, OA01.03
11:00 - 11:15 | Presenter: Rocco Trisolini
- Abstract
No abstract available for this presentation
-
+
OA01.05 - Cryobiopsy Compared with Forceps Biopsy in Pathological Diagnosis and Biomarker Research in Lung Cancer: A Prospective, Single-Arm Study
11:15 - 11:25 | Presenter: Tomoyuki Naito | Author(s): Hibiki Udagawa, Keisuke Kirita, Takaya Ikeda, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Genichiro Ishii, Koichi Goto
- Abstract
Loading... -
+
OA01.06 - Cone Beam CT Imaging for Transbronchial Navigation in Small Peripheral Pulmonary Lesions
11:25 - 11:35 | Presenter: Erik H.F.M. Van Der Heijden | Author(s): Roel L.J. Verhoeven, Jurgen Fütterer, Wouter Hoefsloot
- Abstract
Loading... -
+
OA01.07 - Ultrathin Bronchoscopy Combined with VBN and EBUS for the Diagnosis of PPLs With or Without Fluoroscopy: A Randomized Trial
11:35 - 11:45 | Presenter: Jiayuan Sun | Author(s): Xiaoxuan Zheng, Fangfang Xie
- Abstract
Loading... -
+
OA01.08 - Discussant - OA01.05, OA01.06, OA01.07
11:45 - 12:00 | Presenter: Mehrnaz Asadi
- Abstract
No abstract available for this presentation
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.01 - Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET)
10:30 - 10:40 | Presenter: Noriko Yanagitani | Author(s): Shinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, Yasuhito Imai, Shizuko Takahara, Takahiro Kawakami, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio, Seiji Yano
- Abstract
Loading... -
+
OA02.02 - Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRAS G12C Inhibitor, Evaluated in NSCLC
10:40 - 10:50 | Presenter: Ramaswamy Govindan | Author(s): Marwan G Fakih, Timothy J Price, Gerald S Falchook, Jayesh Desai, James C Kuo, John H Strickler, John C Krauss, Bob T Li, Crystal S Denlinger, Greg Durm, Jude Ngang, Haby Henary, Gataree Ngarmchamnanrith, Erik Rasmussen, Phuong Khanh Morrow, David S. Hong
- Abstract
Loading... -
+
OA02.03 - The Third Generation EGFR Inhibitor (EGFR-TKI) HS-10296 in Advanced NSCLC Patients with Resistance to First Generation EGFR-TKI
10:50 - 11:00 | Presenter: Shun Lu | Author(s): Qiming Wang, Guojun Zhang, Xiaorong Dong, Cheng-Ta Yang, Yong Song, Gee-Chen Chang, You Lu, Hongming Pan, Chao-Hua Chiu, Zhehai Wang, Jifeng Feng, Jianying Zhou, Xingxiang Xu, Renhua Guo, Jianhua Chen, Haihua Yang, Yuan Chen, Zhuang Yu, Her-Shyong Shiah, Chin-Chou Wang, Nong Yang, Jian Fang, Ping Wang, Kai Wang, Yanping Hu, Jianxing He, Ziping Wang, Jianhua Shi, Shaoshui Chen, Ying Cheng, Wu-Chou Su, Te-Chun Hsia, Jiuwei Cui, yuping Sun, Chih-Hsin Yang
- Abstract
Loading... -
+
OA02.04 - Discussant - OA02.01, OA02.02, OA02.03
11:00 - 11:15 | Presenter: Jon Zugazagoitia
- Abstract
No abstract available for this presentation
-
+
OA02.05 - First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC
11:15 - 11:25 | Presenter: Suresh S Ramalingam | Author(s): Juanita Lopez, Morten Mau-Sorensen, Fiona Thistlethwaite, Sarina Piha-Paul, Shirish Gadgeel, Yvette Drew, Pasi A Jänne, Aaron S. Mansfield, Guang Chen, Ulf Forssmann, Hrefna Kristin Johannsdottir, Nora Pencheva, Annette Ervin-Haynes, Ignace Vergote
- Abstract
Loading... -
+
OA02.06 - The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L)
11:25 - 11:35 | Presenter: Satomi Watanabe | Author(s): Takeharu Yamanaka, Kentaro Ito, Shinya Sakata, Haruko Daga, Takashi Kijima, Katsuya Hirano, Isamu Okamoto, Atsushi Nakamura, TOSHIYUKI Kozuki, Mikiko Ishihara, Koichi Azuma, Takashi Seto, Toshihide Yokoyama, Yuko Oya, Haruki Kobayashi, Kazumi Nishino, Yoshihiro Hattori, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading... -
+
OA02.07 - Phase 3 ALUR Study of Alectinib in Pretreated ALK+ NSCLC: Final Efficacy, Safety and Targeted Genomic Sequencing Analyses
11:35 - 11:45 | Presenter: Juergen Wolf | Author(s): Åslaug Helland, In-Jae Oh, Maria Rita Migliorino, Rafal Dziadziuszko, Javier De Castro Carpeno, Julien Mazieres, Frank Griesinger, Marijana Chlistalla, Andres Cardona, Thorsten Ruf, Kerstin Trunzer, Vlatka Smoljanovic, Silvia Novello
- Abstract
Loading... -
+
OA02.08 - Discussant - OA02.05, OA02.06, OA02.07
11:45 - 12:00 | Presenter: Michael Duruisseaux
- Abstract
No abstract available for this presentation
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- 13:30 - 15:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Moderators:Christine Lee Hann, Makoto Nishio
-
+
OA03.01 - A Non-Randomized, Open-Label, Prospective, Multicenter Study of Apatinib as Second-Line and Later-Line Therapy in Patients with ES-SCLC
13:30 - 13:40 | Presenter: Quan Liu | Author(s): Dong Hua, Junying Xu, Yehong Xu, Meng Chen, Lichun Deng, Jianping Wu, Tong Zhou, Liqin Zhang, Jie Tan, Xingxiang Pu, Yulong Shang, Jun Hua, Yuanqin Li, Wei Cai, Yulan Gu, Xingchen Peng
- Abstract
Loading... -
+
OA03.02 - Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial
13:40 - 13:50 | Presenter: Qiming Wang | Author(s): Ying Cheng, Kai Li, Jianhua Shi, Baohui Han, Lin Wu, Gongyan Chen, Jianxing He, Jie Wang, Haifeng Qin, Xiao-Ling Li
- Abstract
Loading... -
+
OA03.03 - Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Luis Paz-Ares | Author(s): David R Spigel, Yuanbin Chen, Maria Jove, Oscar Juan, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Tiffany Wang, Natalya Nazarenko, Santiago Ponce, Paul A Bunn, Jr
- Abstract
Loading... -
+
OA03.04 - Discussant - OA03.01, OA03.02, OA03.03
14:00 - 14:15 | Presenter: Flavia Amaral Duarte
- Abstract
No abstract available for this presentation
-
+
OA03.05 - Characterization of Genomic Alterations in Chinese LCNEC and SCLC via Comprehensive Genomic Profiling
14:15 - 14:25 | Presenter: Lin Wu | Author(s): Liming Cao, Likun Chen, Bo Zhu, Xiaohua Hu, Gen Lin, Yingcheng Lin, Sheng Zhang, Wenying Peng, Meilin Jiang, Xinru Mao, Tengfei Zhang, Junyi Ye, Lu Zhang
- Abstract
Loading... -
+
OA03.06 - ASCL1, NEUROD1, and POU2F3 Drive Distinct Subtypes of Small Cell Lung Cancer with Unique Therapeutic Vulnerabilities
14:25 - 14:35 | Presenter: Carl M. Gay | Author(s): Lixia Diao, C. Allison Stewart, Yuanxin Xi, Robert J. Cardnell, Stephen Swisher, Jack Roth, Bonnie Glisson, Jing Wang, John Victor Heymach, Lauren Averett Byers
- Abstract
Loading... -
+
OA03.07 - Immune-Related Adverse Events and Clinical Outcome to Anti PD-1 Axis Inhibition in SCLC: A Multicenter Retrospective Analysis
14:35 - 14:45 | Presenter: Biagio Ricciuti | Author(s): abdul rafeh Naqash, Brian Henick, Deepa Rangachari, Jarushka Naidoo, Deepti Venkatraman, Giuseppe Lamberti, Gonzalo Recondo Jr., Jiajia Zhang, Shravanti Macherla, Sameer Baig, Paul Raymond Walker, Kartik Sehgal, Renato Umeton, Lynette M Sholl, Naiyer A Rizvi, Daniel B Costa, Mark Awad
- Abstract
Loading... -
+
OA03.08 - Discussant - OA03.05, OA03.06, OA03.07
14:45 - 15:00 | Presenter: Herbert H. Loong
- Abstract
No abstract available for this presentation
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.01 - A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Cell Lung Cancer
15:15 - 15:25 | Presenter: Lyudmila Bazhenova | Author(s): Mary Redman, Scott Gettinger, Fred R. Hirsch, Philip Mack, Lawrence H Schwartz, David R Gandara, Jeffrey D Bradley, Thomas Stinchcombe, Natasha B Leighl, Suresh S Ramalingam, Susan Tavernier, Katherine Minichiello, Karen Kelly, Vassiliki A Papadimitrakopoulou, Roy S. Herbst
- Abstract
Loading... -
+
OA04.02 - CheckMate 817: First-Line Nivolumab + Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC
15:25 - 15:35 | Presenter: Fabrice Barlesi | Author(s): Clarisse Audigier-Valette, Enriqueta Felip, Tudor-Eliade Ciuleanu, Kevin Jao, Erika Rijavec, Laszlo Urban, Jean-Sébastien Aucoin, Cristina Zannori, Karim Vermaelen, Osvaldo Aren Frontera, Neal Ready, Alessandra Curioni Fontecedro, Helena Linardou, Elena Poddubskaya, Jürgen R. Fischer, Ingrid Iordan, Harry JM Groen, Rathi N Pillai, Sunney Li, Joseph Fiore, Han Chang, Angelic Acevedo, Luis Paz-Ares
- Abstract
Loading... -
+
OA04.03 - A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
15:35 - 15:45 | Presenter: Caicun Zhou | Author(s): Gongyan Chen, yunchao Huang, Jianying Zhou, LiZhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, LiPing Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Faguang Jin, Hongjun Gao, Guangyu An, Cuimin Ding, Xiaodong Jiang, Jianping Xiong, Xiangdong Zhou, Sheng Hu, Ping Lu, Anwen Liu, Shuliang Guo, Jianjin Huang, Chengchu Zhu, Jian Zhao, Beili Gao, Yinglan Chen, Chengping Hu, Jian Zhang, Hongmei Zhang, Hui Zhao, Yujie Zhou, Yanfei Tai
- Abstract
Loading... -
+
OA04.04 - Discussant - OA04.01, OA04.02, OA4.03
15:45 - 16:00 | Presenter: Martin Sebastian
- Abstract
No abstract available for this presentation
-
+
OA04.05 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC
16:00 - 16:10 | Presenter: Corey Jay Langer | Author(s): Shirish Gadgeel, Hossein Borghaei, Amita Patnaik, Steven F. Powell, Ryan D Gentzler, James Chih-Hsin Yang, Matthew A. Gubens, Lecia Sequist, Mark Awad, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Vassiliki A Papadimitrakopoulou
- Abstract
Loading... -
+
OA04.06 - Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC
16:10 - 16:20 | Presenter: Marina Chiara Garassino | Author(s): Delvys Rodriguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Giovanna Speranza, Martin Reck, Rina Hui, Michael Boyer, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Edward Garon
- Abstract
Loading... -
+
OA04.07 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial
16:20 - 16:30 | Presenter: Naiyer A Rizvi | Author(s): Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Myung-Ju Ahn, Vassiliki A Papadimitrakopoulou, John Victor Heymach, Urban Scheuring, Brandon Higgs, Jiabu Ye, Michael Kuziora, Song Wu, Feng Liu, Han Si, Solange Peters
- Abstract
Loading... -
+
OA04.08 - Discussant - OA04.05, OA04.06, OA4.07
16:30 - 16:45 | Presenter: Melissa Johnson
- Abstract
No abstract available for this presentation
-
+
OA05 - Increasing the Impact of Nursing and Allied Health Professional Interventions in Lung Cancer Care
- 15:15 - 16:45
- 9/08/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Oral Session
- Track: Nursing and Allied Professionals
- Moderators:Dianne Zawisza, Maria Guerin
-
+
OA05.01 - A Prospective Study of Swallowing and Voice Outcomes After Treatment for Small-Cell Lung Cancer
15:15 - 15:25 | Presenter: Jacqui Frowen | Author(s): Karla Gough, Jo Phipps-Nelson, Rhys Hughes, Shankar Siva, Allison Drosdowsky, Benjamin J Solomon, Nicole Kiss, Mary Duffy, David Ball
- Abstract
Loading... -
+
OA05.02 - Patient Experience, Expectations and Knowledge: Lung Cancer in Australia
15:25 - 15:35 | Presenter: Catherine Holliday
- Abstract
Loading... -
+
OA05.03 - Development of a Fatigue and Breathlessness Group for Thoracic Oncology Patients
15:35 - 15:45 | Presenter: Pippa Labuc | Author(s): Faye Dickinson
- Abstract
Loading... -
+
OA05.04 - Discussant - OA05.01, OA05.02, OA05.03
15:45 - 15:55 | Presenter: Melissa Jane Culligan
- Abstract
No abstract available for this presentation
-
+
OA05.05 - Transforming the Patient Experience in Lung Cancer Through the Use of Clinical Nurse Specialist Virtual Clinics - The Liverpool Experience
15:55 - 16:05 | Presenter: Andrea Vanessa McIver, Nicola Maddock | Author(s): Joanne Dunbar, Sophie Sanders, Martin Ledson, Martin Walshaw, Colin Smyth
- Abstract
Loading... -
+
OA05.06 - Nursing Intervention on Immuno-Related Adverse Events in Lung Cancer Patients
16:05 - 16:15 | Presenter: Monica Arellano | Author(s): Isabel Brao, M. Paz Fernández
- Abstract
Loading... -
+
OA05.07 - Co-Operation Between the Cities of Glasgow and Bethlehem and the Development of a Cancer Nursing Diploma at Bethlehem University Palestine
16:15 - 16:25 | Presenter: Gerry O Hare
- Abstract
Loading... -
+
OA05.08 - Discussant - OA05.05, OA05.06, OA05.07
16:25 - 16:35 | Presenter: Mary Duffy
- Abstract
No abstract available for this presentation
-
+
OA05.09 - IASLC Lectureship Award for Nursing and Allied Health
16:35 - 16:45 | Presenter: Kahren White
- Abstract
No abstract available for this presentation